Jane Street Group, LLC Aeglea Bio Therapeutics, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.11 - $0.46 $1,266 - $5,296	11,515 Added 26.93%	54,278 $24,000
Q1 2023 May 15, 2023	BUY	$0.29 - $0.61 $12,401 - $26,085	42,763 New	42,763 $12,000
Q4 2020 Feb 17, 2021	SELL	$7.02 - $9.83 $83,404 - $116,790	-11,881 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$6.51 - $9.33 $3,925 - $5,625	-603 Reduced 4.83%	11,881 $84,000
Q2 2020 Aug 17, 2020	BUY	$4.01 - $11.04 $50,060 - $137,823	12,484 New	12,484 $115,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.